A Phase 3 Study of Pembrolizumab Versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394
Liver Cancer(2024)
关键词
Health-related quality of life,Patient-reported outcomes,KEYNOTE-394,PD-1 inhibitor,Previously treated patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要